ERBB2 and breast carcinoma: Molecular ITH determined by genetic and epigenetic alterations is mirrored at the level of the phenotype of breast cancer cells, which is exemplified by the heterogeneity in the expression of the HER2 receptor caused by the heterogeneous distribution of HER2 gene amplification [45,46].